CVE-2006-1008

Public Exploit

Description

Multiple cross-site scripting (XSS) vulnerabilities in N8cms 1.1 and 1.2 allow remote attackers to inject arbitrary web script or HTML via the (1) dir and (2) page_id parameter to (a) index.php and (3) userid parameter to (b) mailto.php. NOTE: it is possible that issues 1 and 2 are resultant from SQL injection.

5.8

CVSS

Severity: Medium

CVSS 2.0 •

EPSS 1.15% Top 25%

Vendor Advisory secunia.com

Affected: n/a n/a

References

Link	Tags
http://securityreason.com/securityalert/562	third party advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/24975	vdb entry
http://www.vupen.com/english/advisories/2006/0779	vdb entry
http://www.securityfocus.com/archive/1/427222/100/0/threaded	mailing list
http://secunia.com/advisories/19068	third party advisory vendor advisory
http://biyosecurity.be/bugs/n8cms.txt	exploit
https://exchange.xforce.ibmcloud.com/vulnerabilities/25126	vdb entry
http://www.securityfocus.com/bid/16858	vdb entry

Frequently Asked Questions

What is the severity of CVE-2006-1008?: CVE-2006-1008 has been scored as a medium severity vulnerability.
How to fix CVE-2006-1008?: To fix CVE-2006-1008, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2006-1008 being actively exploited in the wild?: It is possible that CVE-2006-1008 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.

This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.